Stock listing

IPN Stock Price, News, Filings & Events — Ipsen Sa

Selected listing: IPN · EURONEXT · EUR · FR

This page tracks Ipsen Sa's IPN:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IPN:EURONEXT. IPN:EURONEXT is the stock-level entry point for investors researching Ipsen Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ipsen Sa is a public company listed on the French market under the ticker IPN, with a market capitalization of approximately €15.34 billion. The company is involved in the biopharmaceutical sector, focusing on innovative medicines for various therapeutic areas. Ipsen is committed to improving patient outcomes through its research and development efforts.

IPN:EURONEXTEURFRUpdated September 5, 2026
Ipsen Sa logo
Ticker
IPN:EURONEXT
Asset type
Stock
Market cap
$16.21B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
EURONEXT
Currency
EUR

Ipsen Sa IPN:EURONEXT stock context

This page tracks Ipsen Sa's IPN:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IPN:EURONEXT. IPN:EURONEXT is the stock-level entry point for investors researching Ipsen Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ipsen Sa is a public company listed on the French market under the ticker IPN, with a market capitalization of approximately €15.34 billion. The company is involved in the biopharmaceutical sector, focusing on innovative medicines for various therapeutic areas. Ipsen is committed to improving patient outcomes through its research and development efforts.

Latest news from Ipsen Sa

All Ipsen Sa news →

Ipsen Sa earnings calls

Research Ipsen Sa

Alternate listings